146 related articles for article (PubMed ID: 35844783)
21. Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways.
Liang X; Qi M; Wu R; Liu A; Chen D; Tang L; Chen J; Hu X; Li W; Zhan L; Shao C
Int J Oncol; 2018 Dec; 53(6):2671-2682. PubMed ID: 30272271
[TBL] [Abstract][Full Text] [Related]
22. The CircRNA-ACAP2/Hsa-miR-21-5p/ Tiam1 Regulatory Feedback Circuit Affects the Proliferation, Migration, and Invasion of Colon Cancer SW480 Cells.
He JH; Li YG; Han ZP; Zhou JB; Chen WM; Lv YB; He ML; Zuo JD; Zheng L
Cell Physiol Biochem; 2018; 49(4):1539-1550. PubMed ID: 30212824
[TBL] [Abstract][Full Text] [Related]
23. Crosstalk between hypoxia-sensing ULK1/2 and YAP-driven glycolysis fuels pancreatic ductal adenocarcinoma development.
Jia Y; Li HY; Wang Y; Wang J; Zhu JW; Wei YY; Lou L; Chen X; Mo SJ
Int J Biol Sci; 2021; 17(11):2772-2794. PubMed ID: 34345207
[TBL] [Abstract][Full Text] [Related]
24. Low Expression of Rasal2 Promotes Non-small Cell Lung Cancer Metastasis through Ras/ERK Pathway.
Fan D; Yu S; Yang Y; Qu S
Biol Pharm Bull; 2021; 44(7):992-998. PubMed ID: 34193694
[TBL] [Abstract][Full Text] [Related]
25. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
[TBL] [Abstract][Full Text] [Related]
26. Ral GTPase promotes metastasis of pancreatic ductal adenocarcinoma via elevation of TGF-β1 production.
Cao M; Li X; Trinh DA; Yoshimachi S; Goto K; Sakata N; Ishida M; Ohtsuka H; Unno M; Wang Y; Shirakawa R; Horiuchi H
J Biol Chem; 2023 Jun; 299(6):104754. PubMed ID: 37116704
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
28. Kindlin-2 induced by TGF-β signaling promotes pancreatic ductal adenocarcinoma progression through downregulation of transcriptional factor HOXB9.
Zhan J; Song J; Wang P; Chi X; Wang Y; Guo Y; Fang W; Zhang H
Cancer Lett; 2015 May; 361(1):75-85. PubMed ID: 25724625
[TBL] [Abstract][Full Text] [Related]
29. SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation.
Liu J; Bai W; Zhou T; Xie Y; Yang B; Sun J; Wang Y; Li X; Hou X; Liu Z; Fu D; Yan J; Jiang W; Zhao K; Zhou B; Yuan S; Guo Y; Wang H; Chang A; Gao S; Shi L; Huang C; Yang S; Hao J
Gut; 2023 Sep; 72(9):1722-1737. PubMed ID: 36828627
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis.
Salcedo Allende MT; Zeron-Medina J; Hernandez J; Macarulla T; Balsells J; Merino X; Allende H; Tabernero J; Ramon Y Cajal S
Pancreas; 2017 Aug; 46(7):913-920. PubMed ID: 28697132
[TBL] [Abstract][Full Text] [Related]
31. PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer.
Ji Q; Li H; Cai Z; Yuan X; Pu X; Huang Y; Fu S; Chu L; Jiang C; Xue J; Zhang X; Li R
Int J Biol Sci; 2023; 19(6):1894-1909. PubMed ID: 37063425
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of SOX18 correlates with accelerated cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
Wang Y; Guo H; Zhang D; Yu X; Leng X; Li S; Zhu W
Biochem Biophys Res Commun; 2016 Oct; 479(3):510-516. PubMed ID: 27663663
[TBL] [Abstract][Full Text] [Related]
33. NAP1L5 facilitates pancreatic ductal adenocarcinoma progression via TRIM29-mediated ubiquitination of PHLPP1.
Xiao B; Ge Y; Zhao R; Zhang Y; Guo Y; Zhang S; Li B; Qiu P; Chao Z; Zuo S
Biochem Pharmacol; 2023 Nov; 217():115811. PubMed ID: 37717692
[TBL] [Abstract][Full Text] [Related]
34. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
[TBL] [Abstract][Full Text] [Related]
35. RASAL2 activates RAC1 to promote triple-negative breast cancer progression.
Feng M; Bao Y; Li Z; Li J; Gong M; Lam S; Wang J; Marzese DM; Donovan N; Tan EY; Hoon DS; Yu Q
J Clin Invest; 2014 Dec; 124(12):5291-304. PubMed ID: 25384218
[TBL] [Abstract][Full Text] [Related]
36. eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth.
Strnadel J; Choi S; Fujimura K; Wang H; Zhang W; Wyse M; Wright T; Gross E; Peinado C; Park HW; Bui J; Kelber J; Bouvet M; Guan KL; Klemke RL
Cancer Res; 2017 Apr; 77(8):1997-2007. PubMed ID: 28381547
[TBL] [Abstract][Full Text] [Related]
37. Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p.
Zhu D; Zheng S; Fang C; Guo X; Han D; Tang M; Fu H; Jiang M; Xie N; Nie Y; Yao X; Chen Y
Cancer Lett; 2020 May; 477():107-121. PubMed ID: 32120026
[TBL] [Abstract][Full Text] [Related]
38. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.
Zhang Y; Huang J; Li Q; Chen K; Liang Y; Zhan Z; Ye F; Ni W; Chen L; Ding Y
BMC Cancer; 2018 May; 18(1):539. PubMed ID: 29739365
[TBL] [Abstract][Full Text] [Related]
39. Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294/c-Myc axis.
Rong Z; Shi S; Tan Z; Xu J; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Liang C
Mol Cancer; 2021 Aug; 20(1):106. PubMed ID: 34419070
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin.
Zhao X; Gao S; Ren H; Sun W; Zhang H; Sun J; Yang S; Hao J
Cancer Res; 2014 May; 74(9):2455-64. PubMed ID: 24599125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
